Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Curcugen® Goes Beyond the Capsule into Two Formats Consumers Crave


News provided by

DolCas Biotech

Oct 13, 2026, 08:01 ET

Share this article

Share toX

Share this article

Share toX

DolCas Biotech's full-spectrum curcumin extract features in Mānukora® Mānuka  honey and Numin cognitive beverage

LANDING, N.J., Oct. 13, 2026 /PRNewswire/ -- Nutraceutical leader DolCas Biotech, LLC is elevating curcumin supplementation beyond the pill by bringing its Curcugen® "full spectrum" curcuminoid complex into two new functional applications via two strategic collaborations. DolCas Biotech will present them at SupplySide Global 2026, Booth #6011.

Continue Reading
DolCas Biotech’s Curcugen® features in Mānukora® Mānuka honey
DolCas Biotech’s Curcugen® features in Mānukora® Mānuka honey
DolCas Biotech’s Curcugen® features in Numin cognitive beverage
DolCas Biotech’s Curcugen® features in Numin cognitive beverage

DolCas Biotech teamed up with the New Zealand-based Mānuka honey company Mānukora®, Ltd. to incorporate Curcugen® into its "Body Recovery & Gut" formulation. The new functional honey combines raw MGO 850+ Mānuka honey with DolCas Biotech's proprietary, full-spectrum turmeric. The formula also includes concentrated ginger and Sicilian lemon oil.

"Honey and turmeric have a long history together," informs Benjamin Nahar, Head of Product Development and Herbal Science at Mānukora. "In Ayurveda, honey is traditionally described as a yogavahi, a medium that delivers and enhances the effects of the herbs it's combined with. Pairing turmeric with Mānuka felt less like inventing something new and more like bringing a traditional idea into a modern formulation."

Just a spoonful of Mānuka

"Curcugen lets us create formulations like this in a way that matches our philosophy," Nahar continues. "Curcugen is a full-spectrum extract that retains the plant's naturally occurring oils and constituents. It boasts substantially greater bioavailability compared to a standard 95% curcumin extract, allowing us to deliver meaningful potency without having to reduce it to isolated curcuminoids that are typically difficult for the body to absorb. The result is earthy and warming MGO 850+ Mānuka honey with a citrus-bright finish—a rich flavor consumers will actually crave."

Curcugen® is a 100% turmeric-derived, full spectrum curcuminoid complex made from the whole turmeric rhizome and clinically demonstrated to provide enhanced bioavailability. It requires no added bioenhancers and provides the naturally occurring curcuminoids curcumin, demethoxycurcumin (DMC), and bisdemethoxycurcumin (BDMC) as well as native turmeric essential oils and other bioactive components that have been retained through a proprietary manufacturing process.

No formulation limits

Human pharmacokinetic research demonstrates more than 50-fold greater bioavailability of total curcuminoids with Curcugen® compared with a standard curcuminoid extract, supporting its potential for low-dose formulation. Together with its demonstrated safety and tolerability, Self-Affirmed GRAS status for specified uses, mild flavor, water dispersibility, and versatile delivery characteristics broaden the possible applications of Curcugen® beyond conventional capsules and tablets to functional foods, beverages and other innovative delivery systems.

"For product developers, the conversation is changing," explains K G Rao, founder and CEO of DolCas Biotech. "It's no longer just about how much curcumin can you absorb, but what can you create with Curcugen®. Curcugen® is redefining what's possible with this powerful nutraceutical ingredient."

DolCas Biotech's goal in creating Curcugen® was to preserve turmeric's unique qualities while creating an ingredient that is highly absorbable, clinically meaningful, gentle, formulation-friendly, and versatile. "We're giving product developers the freedom to explore applications that are typically challenging for conventional turmeric extracts," adds Rao. "The future of curcumin no longer needs to be limited to pills. With Curcugen, it could be a spoonful of Mānukora's premium Mānuka honey, a morning beverage, a mid-morning ready-to-drink wellness shot, an on-the-go gummy or piece of chocolate, or an entirely new functional food."

Curcugen® in a new "decision fatigue" drink

Curcugen® also features as a key ingredient in Numin, a functional beverage by SLS Performance Pte., Ltd. developed to address "decision fatigue." Building on Numin's previously published human research, Numin's current formulation incorporates Curcugen® alongside complementary ingredients, leveraging its enhanced bioavailability, turmeric-derived profile and formulation versatility. Available in convenient orange-flavored, single-serve powder sachets that disperse readily in liquids, Numin's internal evaluations report improved mental clarity and sustained decision-making, with effects observed within approximately 60 minutes and lasting up to six hours.

"We didn't want to just stack trendy ingredients and call it cognitive support," says Arun Hozack, CEO of Numin. "We wanted a formulation validated on outcomes people would actually feel. Fewer reckless choices, fewer default choices, and sustained clarity late into the day. That meant building it around a real mechanism, and testing the finished product, not just its parts. Curcugen® stood out early for exactly that reason. It has strong clinical grounding, a clean turmeric-derived profile, and the bioavailability and formulation flexibility to actually perform inside a functional beverage."

Numin targets professionals such as executives, traders, consultants, and managers whose performance depends on sustained decision quality. It is ideal for formulators who recognize decision fatigue as an emerging opportunity at the intersection of cognitive performance, functional beverages, and human performance.

Curcugen® has been clinically investigated across areas including exercise and recovery, gastrointestinal wellness, knee joint health, bioavailability, and safety, while new and ongoing studies are exploring additional health categories and biological pathways. "Several exciting research programs are underway, some of which could take Curcugen® into new categories not traditionally associated with curcumin," concludes Rao.

Visit DolCas Biotech at SupplySide Global 2026 at Booth #6011 to experience Curcugen® applications, discuss the clinical science, and explore formulation possibilities. Brand owners and product innovators are invited to experience its flagship curcumin extract in new ways. Visitors are welcome to taste Morikol® marine collagen tripeptide in chocolate bites. recharge with a shot of Morikol® Espresso.

Taste it. Experience it. Discover what's possible.

For more information:

Company Contact:

Press Contact:

DolCas Biotech, LLC

NUTRiPR

K. G. Rao

Founder and CEO of DolCas Biotech

Liat Simha

Tel: +972-9-974-2893

Email: [email protected]

Email: [email protected] 

Web: www.dolcas-biotech.com

Website: www.nutripr.com 

SOURCE DolCas Biotech

21%

more press release views with 
Request a Demo

Modal title

Also from this source

DolCas Biotech: Beauty-From-Within Collagen Tripeptide Gets New Delivery Format

DolCas Biotech: Beauty-From-Within Collagen Tripeptide Gets New Delivery Format

DolCas Biotech, LLC, a leader in clinically researched nutraceutical ingredients, announces the introduction of a new format for its Morikol® marine...

DolCas Biotech Marine Collagen Boosts the Morning Coffee Break

DolCas Biotech Marine Collagen Boosts the Morning Coffee Break

Leading nutraceutical developer DolCas Biotech, LLC is expanding Morikol®, its marine collagen into the functional beverage space, particularly...

More Releases From This Source

Explore

Food & Beverages

Food & Beverages

Beverages

Beverages

Organic Food

Organic Food

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.